Education
About Us
Working with TipRanks
Follow Us
Aclaris Therapeutics (DE:8AT)
FRANKFURT:8AT
Aclaris Therapeutics (8AT) Ownership Overview
29.40% Insiders
4.88% Mutual Funds
0.42% Other Institutional Investors
5.87% ETFs
59.43% Public Companies and Individual Investors
The ownership structure of Aclaris Therapeutics (DE:8AT) stock is a mix of institutional, retail, and individual investors. Approximately 11.17% of the company’s stock is owned by Institutional Investors, 29.40% is owned by Insiders, and 59.43% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Nov 20, 2024 | Anand Mehra Director | xxxxxxxxxxxxx | $1499999 |
| Aug 05, 2024 | Braden Michael Leonard >10% Owner | xxxxxxxxxxxxx | $216132 |
| Aug 05, 2024 | Braden Michael Leonard >10% Owner | xxxxxxxxxxxxx | $255471 |
| Jul 31, 2024 | Braden Michael Leonard >10% Owner | xxxxxxxxxxxxx | $357849 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $35146 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $11573334 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 28,293,975 | Insider | 26.44% | 61,907,217 | |
| 4,666,667 | Institution | 4.36% | 10,210,667 | |
| 3,084,125 | Institution | 2.88% | 6,748,066 | |
| 2,936,160 | Institution | 2.74% | 6,424,318 | |
| 2,769,939 | Institution | 2.59% | 6,060,627 | |
| 1,460,718 | Insider | 1.36% | 3,196,051 | |
| 710,030 | Insider | 0.66% | 1,553,546 | |
| 706,504 | Institution | 0.66% | 1,545,831 | |
| 630,160 | Institution | 0.59% | 1,378,790 | |
| 443,622 | Insider | 0.41% | 970,645 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,936,160 | Institution | 2.74% | 6,424,318 | |
| 706,504 | Institution | 0.66% | 1,545,831 | |
| 630,160 | Institution | 0.59% | 1,378,790 | |
| 262,958 | Institution | 0.25% | 575,352 | |
| 197,019 | Institution | 0.18% | 431,078 | |
| 176,318 | Institution | 0.16% | 385,784 | |
| 88,595 | Institution | 0.08% | 193,846 | |
| 73,649 | Institution | 0.07% | 161,144 | |
| 44,964 | Institution | 0.04% | 98,381 | |
| 42,500 | Institution | 0.04% | 92,990 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Aclaris Therapeutics (DE:8AT)?
According to the latest TipRanks data, approximately 0.42% of the company's stock is held by institutional investors, 29.40% is held by insiders, and 59.43% is held by retail investors.
What percentage of Aclaris Therapeutics (DE:8AT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.42% of Aclaris Therapeutics (DE:8AT) stock is held by institutional investors.
What percentage of Aclaris Therapeutics (DE:8AT) stock is held by retail investors?
According to the latest TipRanks data, approximately 59.43% of Aclaris Therapeutics (DE:8AT) stock is held by retail investors.
Who owns the most shares of Aclaris Therapeutics (DE:8AT)?
Braden Michael Leonard owns the most shares of Aclaris Therapeutics (DE:8AT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.